Today: 8 June 2026
Browse Category

NSE:CASTROLIND 25 December 2025 - 26 December 2025

BP’s $10.1bn Castrol Deal: Stonepeak Buys 65% Stake as Castrol India Open Offer Sets ₹194.04 Price

BP’s $10.1bn Castrol Deal: Stonepeak Buys 65% Stake as Castrol India Open Offer Sets ₹194.04 Price

BP will sell 65% of Castrol to Stonepeak for an enterprise value of $10.1 billion, retaining a 35% stake. Stonepeak and CPPIB must launch an open offer for up to 26% of Castrol India at ₹194.04 per share, a slight premium to recent prices. BP expects $6 billion in net proceeds, aiming to cut debt. The deal is set to close by end-2026, pending approvals.
26 December 2025
····
BP sells 65% of Castrol to Stonepeak in $10.1bn deal as Castrol India open offer follows

BP sells 65% of Castrol to Stonepeak in $10.1bn deal as Castrol India open offer follows

BP will sell a 65% stake in Castrol to Stonepeak, valuing the lubricants business at $10.1 billion. The deal will net BP about $6 billion and leave it with a 35% stake in a new joint venture. CPP Investments will support the transaction with up to $1.05 billion. Closing is expected by the end of 2026, pending regulatory approval.
25 December 2025
····
Castrol India Stock in Focus on 25 Dec 2025: Open Offer at ₹194.04 After BP Sells Castrol Stake to Stonepeak

Castrol India Stock in Focus on 25 Dec 2025: Open Offer at ₹194.04 After BP Sells Castrol Stake to Stonepeak

BP agreed to sell a 65% stake in Castrol to Stonepeak for $10.1 billion, triggering a mandatory open offer for up to 26% of Castrol India at ₹194.04 per share. CPP Investments will invest up to $1.05 billion for an indirect stake. Castrol India shares jumped 9% to ₹202.40 on December 24 after the news. The transaction is expected to close by end-2026, pending regulatory approvals.
25 December 2025
···

Stock Market Today

  • Singapore Stocks Slide 1.9% Amid Global Tech Sell-off and Middle East Tensions
    June 8, 2026, 5:33 AM EDT. Singapore's Straits Times Index (STI) dropped 1.9% to 4,955.47 on June 8, pressured by a global slump in technology shares and escalating Middle East conflicts. Major tech stocks, including AEM and UMS, fell between 3-4%, while precision engineering and AI-related firm InnoTek declined over 4%. Regional markets fell sharply, with South Korea's Kospi down 8.1%, Japan's Nikkei by 4%, and Taiwan's benchmark by 3.5%. Key chipmakers Samsung Electronics and SK Hynix saw steep losses of 9.5% and 6.5%, respectively. The tech sell-off followed Broadcom's weaker-than-expected revenue guidance, raising fears of an AI investment bubble. Local banks DBS, OCBC, and UOB also declined amid rising inflation concerns driven by higher oil prices and geopolitical risks. The volatile market reflects investor caution ahead of SpaceX's Nasdaq IPO slated for June 12.

Latest articles

MPS Shares Surge After Intesa Launches €30.6 Billion Offer

MPS Shares Surge After Intesa Launches €30.6 Billion Offer

8 June 2026
Banca Monte dei Paschi di Siena shares soared 10.91% to 9.921 euros after Intesa Sanpaolo launched an unsolicited €30.6 billion cash-and-share bid, offering a 12.5% premium and triggering takeover rules that block MPS from merging with Banco BPM without shareholder approval, as investors weigh regulatory hurdles, branch disposals, and the fight for control of key Italian financial assets.
Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

8 June 2026
Hyperscale Data’s $0.21/share buyback offer sits 39% above Friday’s $0.1510 close, with the tender expiring late Monday and covering up to 5.1% of shares; the company cites a “material disconnect” with net book value at $0.26/share, while ending its ATM stock-sale program and holding $51.8M in Bitcoin as of May 31.
Zealand Pharma Shares Sink 25% After Trial Results

Zealand Pharma Shares Sink 25% After Trial Results

8 June 2026
Zealand Pharma shares plunged 26.02% to 241.40 Danish crowns after investors focused on a 19% discontinuation rate for Boehringer’s obesity drug survodutide in the SYNCHRONIZE-1 trial, far higher than the 2.9% for placebo, despite strong fat-loss data, making the stock the worst performer on Europe’s STOXX 600 in early trade.
Intel’s AI Stock Run Stalls; Monday Premarket Move Fails to Settle It

Intel’s AI Stock Run Stalls; Monday Premarket Move Fails to Settle It

8 June 2026
Intel shares rose 1.6% to $100.74 in pre-market trading Monday, partly rebounding from Friday’s 7.9% drop that followed a strong U.S. jobs report and a tech selloff; investors now face a key test as Intel’s AI partnerships with Foxconn and others lack visible orders or financial details, while options pricing signals potential for another 9% stock move this week amid inflation data and shifting rate expectations.
Nvidia’s $5 Trillion Valuation Gets Put to the Test Monday

Nvidia’s $5 Trillion Valuation Gets Put to the Test Monday

8 June 2026
Nvidia shares hovered near Friday’s 6% drop and $300 billion market cap loss despite new South Korean AI deals, as chip stocks reeled from fears of higher U.S. rates and regulatory risks; investors await Monday’s open to see if fresh partnerships can offset sector volatility and valuation pressure.
Go toTop